These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 15548330)
1. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Lee TJ; Sartor O; Luftig RB; Koochekpour S Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330 [TBL] [Abstract][Full Text] [Related]
2. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
3. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Koochekpour S; Sartor O; Lee TJ; Zieske A; Patten DY; Hiraiwa M; Sandhoff K; Remmel N; Minokadeh A Prostate; 2004 Oct; 61(2):114-23. PubMed ID: 15305334 [TBL] [Abstract][Full Text] [Related]
4. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Koochekpour S; Sartor O; Hiraiwa M; Lee TJ; Rayford W; Remmel N; Sandhoff K; Minokadeh A; Patten DY Asian J Androl; 2005 Jun; 7(2):147-58. PubMed ID: 15897971 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
6. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Venkateswarlu S; Dawson DM; St Clair P; Gupta A; Willson JK; Brattain MG Oncogene; 2002 Jan; 21(1):78-86. PubMed ID: 11791178 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066 [TBL] [Abstract][Full Text] [Related]
8. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Poh TW; Pervaiz S Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. Yu C; Mao X; Li WX Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways. Kraus S; Levy G; Hanoch T; Naor Z; Seger R Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells. Campana WM; Darin SJ; O'Brien JS J Neurosci Res; 1999 Aug; 57(3):332-41. PubMed ID: 10412024 [TBL] [Abstract][Full Text] [Related]
12. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells. Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690 [TBL] [Abstract][Full Text] [Related]
13. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
15. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
16. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613 [TBL] [Abstract][Full Text] [Related]
17. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415 [TBL] [Abstract][Full Text] [Related]
18. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Uzgare AR; Isaacs JT Cancer Res; 2004 Sep; 64(17):6190-9. PubMed ID: 15342404 [TBL] [Abstract][Full Text] [Related]
19. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
20. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells. Moon DO; Lee KJ; Choi YH; Kim GY Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]